Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis.

Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):20-38. doi: 10.1158/1055-9965.EPI-11-0834. Epub 2011 Oct 25. Review.

2.

Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies.

Qi ZY, Shao C, Zhang X, Hui GZ, Wang Z.

PLoS One. 2013 Jul 16;8(7):e68695. doi: 10.1371/journal.pone.0068695. Print 2013.

3.

Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women.

Freedman ND, Chow WH, Gao YT, Shu XO, Ji BT, Yang G, Lubin JH, Li HL, Rothman N, Zheng W, Abnet CC.

Gut. 2007 Dec;56(12):1671-7. Epub 2007 Jul 12.

4.

Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study.

Wang Z, Butler LM, Wu AH, Koh WP, Jin A, Wang R, Yuan JM.

Int J Cancer. 2016 Jun 15;138(12):2837-45. doi: 10.1002/ijc.30024. Epub 2016 Mar 10.

5.

Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis.

Qi ZY, Shao C, Huang YL, Hui GZ, Zhou YX, Wang Z.

PLoS One. 2013 Dec 27;8(12):e83261. doi: 10.1371/journal.pone.0083261. eCollection 2013.

6.

Reproductive history and risk of colorectal cancer in postmenopausal women.

Zervoudakis A, Strickler HD, Park Y, Xue X, Hollenbeck A, Schatzkin A, Gunter MJ.

J Natl Cancer Inst. 2011 May 18;103(10):826-34. doi: 10.1093/jnci/djr101. Epub 2011 Mar 29.

7.

Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system.

Frise S, Kreiger N, Gallinger S, Tomlinson G, Cotterchio M.

Ann Epidemiol. 2006 Dec;16(12):908-16. Epub 2006 Jul 13.

PMID:
16843679
8.

Menstrual factors, reproductive factors and lung cancer risk: a meta-analysis.

Zhang Y, Yin Z, Shen L, Wan Y, Zhou B.

Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):701-19. doi: 10.3779/j.issn.1009-3419.2012.12.04.

9.

Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.

Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW.

Arthritis Rheum. 2007 Apr;56(4):1251-62.

10.

Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies.

Caini S, Gibelli B, Palli D, Saieva C, Ruscica M, Gandini S.

Cancer Causes Control. 2015 Apr;26(4):511-8. doi: 10.1007/s10552-015-0546-z. Epub 2015 Mar 10. Review.

PMID:
25754110
11.

Sex steroid hormone exposures and risk for meningioma.

Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ.

J Neurosurg. 2003 Nov;99(5):848-53.

PMID:
14609164
12.
13.

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.

PMID:
12186605
15.

Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies.

Tang B, Lv J, Li Y, Yuan S, Wang Z, He S.

Medicine (Baltimore). 2015 Feb;94(7):e177. doi: 10.1097/MD.0000000000000177.

16.

Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies.

Zong H, Xu H, Geng Z, Ma C, Ming X, Shang M, Li K, He X, Du H, Zhao J, Cao L.

Tumour Biol. 2014 Nov;35(11):11579-86. doi: 10.1007/s13277-014-2448-1. Epub 2014 Aug 19.

PMID:
25135427
17.

Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study.

Cantwell MM, Lacey JV Jr, Schairer C, Schatzkin A, Michaud DS.

Int J Cancer. 2006 Nov 15;119(10):2398-401.

18.

Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition.

Duell EJ, Travier N, Lujan-Barroso L, Boutron-Ruault MC, Clavel-Chapelon F, Palli D, Krogh V, Mattiello A, Tumino R, Sacerdote C, Rodriguez L, Sanchez-Cantalejo E, Navarro C, Barricarte A, Dorronsoro M, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Bueno-de-Mesquita HB, Jeurnink SM, Numans ME, Peeters PH, Lagiou P, Valanou E, Trichopoulou A, Kaaks R, Lukanova-McGregor A, Bergman MM, Boeing H, Manjer J, Lindkvist B, Stenling R, Hallmans G, Dahm CC, Overvad K, Olsen A, Tjonneland A, Bakken K, Lund E, Jenab M, McCormack V, Rinaldi S, Michaud D, Mouw T, Nesi G, Carneiro F, Riboli E, González CA.

Am J Epidemiol. 2010 Dec 15;172(12):1384-93. doi: 10.1093/aje/kwq321. Epub 2010 Nov 4.

PMID:
21051447
19.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
20.

Sex hormones and headache.

Silberstein SD.

Rev Neurol (Paris). 2000;156 Suppl 4:4S30-41. Review.

PMID:
11139745

Supplemental Content

Support Center